As for Ebola, there is absolutely no market at all, so the only reason we have two vaccines in late-stage clinical trials now, is actually because of a somewhat misguided fear.
Y para el Ébola no hay mercado en absoluto, y por eso, la única razón por la que hay dos vacunas en las últimas fases del ensayo